FindMyKOL
Clinical trialNCT05795361AvailableExpanded Access

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

SponsorTakedaHunter Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

As the HGT-HIT-046 (NCT01506141) and SHP609-302 (NCT02412787) studies are completed and closed, this post-trial access (PTA) program provides TAK-609 to participants in these studies for whom the benefit:risk ratio of continued treatment with idursulfase-IT remains positive.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Queensland Childrens Hospital

    South Brisbane, Queensland, Australia

    Anita Inwood
    Available
Mexico
  • Instituto Nacional de Pediatria

    Coyoacán, Mexico City, Mexico

    Matilde Ruiz-Garcia
    Available
  • H.C.U. de Valladolid

    Valladolid, Mexico

    Margarita Castro Rey
    Available
Spain
  • Hospital Universitario Reina Sofia

    Córdoba, Spain

    Mercedes Gil Campos
    Available
United Kingdom
  • Royal Manchester Children'S Hospital - Ppds

    Manchester, United Kingdom

    Simon Jones
    Available
United States
  • Phoenix Childrens Hospital

    Phoenix, Arizona, United States

    Jasmine Knoll
    Available
  • the Regents of the University of California

    Oakland, California, United States

    Paul Harmatz
    Available
  • the Nemours Foundation

    Wilmington, Delaware, United States

    Jeffery Campbell
    Available
  • Jackson Memorial Hospital University of Miami

    Miami, Florida, United States

    Willa Thorson
    Available
  • Ann and Robert H Lurie Childrens Hospital of Chicago

    Chicago, Illinois, United States

    Barbara Burton
    Available
  • Washington University

    Washington, Missouri, United States

    Dorothy Grange
    Available
  • Board of Regents of the University of Nebraska

    Omaha, Nebraska, United States

    William Rizzo
    Available
  • Joseph M. Sanzari Children'S Hospital

    Hackensack, New Jersey, United States

    Helio Pedro
    Available
  • Nyu Langone Medical Center

    New York, New York, United States

    Devorah Segal
    Available
  • the University of North Carolina

    Chapel Hill, North Carolina, United States

    Joesph Muenzer
    Available
  • the Cleveland Clinic Foundation

    Cleveland, Ohio, United States

    Rabi Hanna
    Available
  • Randall Children'S Hospital at Legacy Emanuel

    Portland, Oregon, United States

    George Anadiotis
    Available
  • the Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Can Ficicioglu
    Available
  • Upmc Childrens Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    Damara Ortiz
    Available
  • Vanderbilt Children'S Hospital

    Nashville, Tennessee, United States

    Neena Agrawal
    Available
  • Division of Medical Genetics, University of Utah

    Salt Lake City, Utah, United States

    David Viskochil
    Available
  • Seattle Children'S Hospital - Pin

    Seattle, Washington, United States

    Emily Shelkowitz
    Available

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Idursulfase-IT
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
13 Apr 2026
Registered enrollment
—
Registry id
NCT05795361

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.